NASDAQ: NOTVInotiv Inc Stock Ownership - Who owns Inotiv?
Insider buying vs selling
Have Inotiv Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| R. Matthew Neff | Director | 2025-07-01 | 2,000 | $1.81 | $3.62kSell |
| R. Matthew Neff | Director | 2025-06-02 | 2,000 | $2.62 | $5.25kSell |
| Mary Theresa Coelho | Director | 2025-04-01 | 5,500 | $2.35 | $12.91kSell |
| Jeffrey Brennan Freeman | VP-Finance Corp. Controller | 2025-02-18 | 1,339 | $4.05 | $5.42kSell |
| Beth Taylor | Chief Financial Officer | 2025-02-18 | 4,370 | $4.01 | $17.51kSell |
| John E. Sagartz | Chief Strategy Officer | 2025-02-18 | 2,113 | $3.94 | $8.32kSell |
| Robert Leasure Jr. | President and CEO | 2025-02-18 | 73,617 | $3.82 | $281.14kSell |
| Jeffrey Arthur Krupp | Chief Human Resources Officer | 2025-02-03 | 472 | $4.18 | $1.97kSell |
| Beth Taylor | Chief Financial Officer | 2025-01-31 | 2,054 | $4.47 | $9.17kSell |
| John E. Sagartz | Chief Strategy Officer | 2025-01-31 | 2,118 | $4.48 | $9.48kSell |
NOTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NOTV insiders and whales buy or sell their stock.
NOTV Shareholders
What type of owners hold Inotiv Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| P2 Capital Partners LLC | 8.58% | 2,946,961 | $5.69M | Insider |
| John E. Sagartz | 5.74% | 1,973,066 | $3.81M | Insider |
| Andrew H. Baker | 5.28% | 1,813,846 | $3.50M | Insider |
| Robert Leasure Jr. | 4.34% | 1,491,322 | $2.88M | Insider |
| Vanguard Group Inc | 3.76% | 1,292,204 | $2.49M | Institution |
| Balyasny Asset Management LP | 3.70% | 1,269,952 | $2.45M | Institution |
| Kimberly L. Sagartz | 3.68% | 1,264,950 | $2.44M | Insider |
| Kennedy Capital Management LLC | 2.92% | 1,003,801 | $1.94M | Institution |
| Scott Cragg | 2.54% | 871,612 | $1.68M | Insider |
| Peter Kissinger | 2.47% | 848,220 | $1.64M | Insider |
NOTV vs Diagnostic & Research Stocks
Inotiv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.